Genetic Variation: Searching for solutions to the missing heritability problem
Rare genetic variants in yeast explain a large amount of phenotypic variation in a complex trait like growth.
- Princeton University, United States
Although most of the 3000 million nucleotides in the human genome are the same in every person on the planet, there are about 90 million sites that can vary between individuals. The source of all phenotypic variation in humans lies in these 90 million genetic variants, and in their interactions with each other and with the environment. Identifying the genetic variants that are involved in a specific trait (such as height or disease status) is a long-standing goal in biology.
Today, researchers rely on genome-wide association studies (GWAS) to find the genetic variants that are relevant to a specific trait. In GWAS the genomes of individuals are analyzed to see if particular genetic variants are correlated with variation in traits of interest. GWAS results have identified hundreds of variants underlying phenotypic variation in humans, mice, fruit flies, rice, maize, and many other taxa. Yet, despite the large number of alleles that have been identified using this technique, the amount of phenotypic variation they explain is just a fraction of what twin and pedigree studies predict is heritable. For example, twin studies have shown that approximately 80% of variation in human height can be explained by genetic factors (Silventoinen et al., 2012). However, the results of the best powered GWAS only explain around 20% of such variation (Wood et al., 2014). This gap is known as the ‘missing heritability problem’.
Rare and low-frequency genetic variants (which have allele frequencies of <1% and <5% respectively) have been proposed as one explanation for the missing heritability problem (reviewed in Gibson, 2012). Such variants are routinely excluded from GWAS studies because when an allele is present in few individuals, the statistical analysis used to draw correlations between traits and alleles is not powerful enough to obtain significant results. As a consequence around 90% of genetic variation in humans and other organisms like yeast has so far gone unexplored (Figure 1A; Auton et al., 2015; Peter et al., 2018). The missing heritability might be hiding in plain sight, but until now, studying the effect of rare alleles on the variation of traits influenced by more than one gene was extremely challenging. Now, in eLife, two independent groups report the results of experiments on yeast which show that rare variants have a fundamental role in phenotypic variation at the population level.
Figure 1
Allele frequency in natural isolates of yeast and in the experimental populations.
(A) Based on a study of 1011 genomes it is known that 93% of the genetic variants in the yeast Saccharomyces cerevisiae are rare (that is, they have a frequency <1%; blue). Moreover, just over 508000 variants (31% of the total; dotted blue) were found in just 1 of the 1011 genomes studied. However, genome-wide association studies (GWAS) tend to focus on the 7% of genetic variants that are common (that is, have a frequency >1%; pink). (B) The frequency of a rare allele can be increased by crossing a yeast isolate carrying the rare variant with an isolate with the alternative (more common) variant. To obtain a variety of isolates with a specific rare allele in different genetic backgrounds, the isolate carrying the rare variant (allele A, dark red) can be crossed with several different isolates with the alternative allele (allele G, pink, yellow, blue, grey). As a result, allele A is more frequent in the experimental panel than in the parental isolates, making it suitable for GWAS analysis. Importantly, regardless of the frequency that any allele reaches in the experimental panel, the real natural frequency can be looked up in the collection of 1011 yeast genomes (panel A).
In a monumental effort, the two groups independently selected a set of wild and domesticated yeast isolates from all over the world and crossed them to generate a genetically diverse panel of thousands of strains (Figure 1B). They then exposed each cross to more than 35 different media conditions and quantified their growth by measuring colony size. As a result of the crossing scheme, genetic variants that were present in just one or a few yeast isolates were now present in hundreds of samples in the experimental panels (Figure 1B). This allowed the groups to include a large number of rare variants (up to 28% of the total) in the GWAS analysis: many of these variants would have been excluded from traditional GWAS studies due to their low allele frequency.
Both groups independently identified thousands of genetic variants associated with growth, and estimated that over half of growth variance can be attributed to additive effects. To determine how variants with different frequencies contributed to phenotypic effects, variants were classified into either rare (<1%) and common (>1%) (Bloom et al., 2019), or rare (<1%), low frequency (1–5%) and common (>5%) (Fournier et al., 2019). This classification was based on 1011 yeast genomes that represent global yeast diversity (Figure 1A; Peter et al., 2018). Strikingly, rare variants contributed a disproportionate amount to phenotypic variation in both studies.
In one study Joseph Schacherer and co-workers at the University of Strasbourg – including Téo Fournier as first author – found that 16% of the GWAS results were rare alleles even when they made up just 4% of all the variants used in the experiments (Fournier et al., 2019). In the other study Joshua Bloom, Leonid Kruglyak and colleagues at UCLA estimated that over half of the observed growth variation can be explained by rare variants, even when they represented only 28% of the variants used (Bloom et al., 2019). The UCLA team also found that the rare variants detected in GWAS tend to have larger effect sizes than common variants, tend to reduce growth ability, and tend to have arisen more recently in evolutionary time.
These results join recent efforts exploring the effect of rare variants on complex traits. For human height it has been shown that rare variants have effect sizes ten times larger than common variants (Marouli et al., 2017), and that together they account for most of the missing heritability in this trait (Wainschtein et al., 2019). In parallel, it was estimated that at least a quarter of gene expression heritability in humans is accounted for by rare variants (Hernandez et al., 2019). The fact that in humans, as well as yeast, the contribution of rare variants to complex traits is now beyond doubt suggests that it may be the same in other species. However, addressing this question in organisms with larger genomes and not amenable to crossing schemes remains challenging. But rest assured, researchers will find a way.
References
-
Rare and common variants: twenty argumentsNature Reviews Genetics 13:135–145.https://doi.org/10.1038/nrg3118
Article and author information
Author details
Publication history
- Version of Record published: December 4, 2019 (version 1)
Copyright
© 2019, Pallares
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,978
- views
-
- 225
- downloads
-
- 10
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Genetic Variation: Searching for solutions to the missing heritability problem
eLife 8:e53018.
https://doi.org/10.7554/eLife.53018
Further reading
-
- Genetics and Genomics
Genome-wide association studies (GWAS) allow to dissect complex traits and map genetic variants, which often explain relatively little of the heritability. One potential reason is the preponderance of undetected low-frequency variants. To increase their allele frequency and assess their phenotypic impact in a population, we generated a diallel panel of 3025 yeast hybrids, derived from pairwise crosses between natural isolates and examined a large number of traits. Parental versus hybrid regression analysis showed that while most phenotypic variance is explained by additivity, a third is governed by non-additive effects, with complete dominance having a key role. By performing GWAS on the diallel panel, we found that associated variants with low frequency in the initial population are overrepresented and explain a fraction of the phenotypic variance as well as an effect size similar to common variants. Overall, we highlighted the relevance of low-frequency variants on the phenotypic variation.
-
- Genetics and Genomics
Uncovering the regulators of cellular aging will unravel the complexity of aging biology and identify potential therapeutic interventions to delay the onset and progress of chronic, aging-related diseases. In this work, we systematically compared genesets involved in regulating the lifespan of Saccharomyces cerevisiae (a powerful model organism to study the cellular aging of humans) and those with expression changes under rapamycin treatment. Among the functionally uncharacterized genes in the overlap set, YBR238C stood out as the only one downregulated by rapamycin and with an increased chronological and replicative lifespan upon deletion. We show that YBR238C and its paralog RMD9 oppositely affect mitochondria and aging. YBR238C deletion increases the cellular lifespan by enhancing mitochondrial function. Its overexpression accelerates cellular aging via mitochondrial dysfunction. We find that the phenotypic effect of YBR238C is largely explained by HAP4- and RMD9-dependent mechanisms. Furthermore, we find that genetic- or chemical-based induction of mitochondrial dysfunction increases TORC1 (Target of Rapamycin Complex 1) activity that, subsequently, accelerates cellular aging. Notably, TORC1 inhibition by rapamycin (or deletion of YBR238C) improves the shortened lifespan under these mitochondrial dysfunction conditions in yeast and human cells. The growth of mutant cells (a proxy of TORC1 activity) with enhanced mitochondrial function is sensitive to rapamycin whereas the growth of defective mitochondrial mutants is largely resistant to rapamycin compared to wild type. Our findings demonstrate a feedback loop between TORC1 and mitochondria (the TORC1–MItochondria–TORC1 (TOMITO) signaling process) that regulates cellular aging processes. Hereby, YBR238C is an effector of TORC1 modulating mitochondrial function.
